These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25421752)

  • 21. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure.
    Scacciatella P; Biava LM; Marra S
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):494-6. PubMed ID: 24399577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Device closure of residual shunt after percutaneous closure of patent foramen ovale.
    Majunke N; Wallenborn J; Baranowski A; Wunderlich N; Sievert H
    EuroIntervention; 2010 Feb; 5(7):833-7. PubMed ID: 20142199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
    Sorensen SG; Smout R; Spruance SL
    J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ; Hagler DJ; Taggart NW
    Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study.
    Sievert H; Wunderlich N; Reiffenstein I; Ruygrok P; Grube E; Buellesfeld L; Meier B; Schofer J; Muller D; Jones RK; Gillam L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1135-43. PubMed ID: 22815250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically apparent long-term electric disturbances in the acute and very long-term of patent foramen ovale device-based closure.
    Rigatelli G; Zuin M; Pedon L; Zecchel R; Dell'Avvocata F; Carrozza A; Zennaro M; Pastore G; Zanon F
    Cardiovasc Revasc Med; 2017 Mar; 18(2):118-122. PubMed ID: 27847261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the new Gore septal and Amplatzer devices for transcatheter closure of patent foramen ovale. Short- and mid-term clinical and echocardiographic outcomes.
    Musto C; Cifarelli A; Fiorilli R; De Felice F; Parma A; Nazzaro MS; Guerra E; Fiorilli F; Violini R
    Circ J; 2013; 77(12):2922-7. PubMed ID: 24004813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents: initial experiences in Japan.
    Kijima Y; Akagi T; Nakagawa K; Taniguchi M; Ueoka A; Deguchi K; Toh N; Oe H; Kusano K; Sano S; Ito H
    Cardiovasc Interv Ther; 2014 Jan; 29(1):11-7. PubMed ID: 23824518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
    Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
    J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coil closure of residual shunt after Amplatzer PFO occlusion.
    Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):720-1. PubMed ID: 20939039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
    Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler.
    van de Wyngaert F; Kefer J; Hermans C; Ovaert C; Pasquet A; Beguin C; Sindic C; Sluysmans T
    Arch Cardiovasc Dis; 2008; 101(7-8):435-41. PubMed ID: 18848685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
    J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen.
    Fischer D; Fuchs M; Schaefer A; Schieffer B; Jategaonkar S; Hornig B; Drexler H; Meyer GP
    J Interv Cardiol; 2008 Apr; 21(2):183-9. PubMed ID: 18312307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
    J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual shunting after percutaneous PFO closure: how to manage and how to close.
    Butera G; Sarabia JF; Saracino A; Chessa M; Piazza L; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):950-8. PubMed ID: 23804551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.